TIAM2
BCLI

Tru Independence Asset Management 2’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Tru Independence Asset Management 2’s Portfolio BCLI Stock Details BCLI Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44,000
Closed -$10.1K – 81
2024
Q3 		$10.1K Buy
+44,000
New +$10.1K 0.01% 82
2023
Q1 		$145K Buy
+44,000
New +$145K 0.15% 73
2022
Q3 		$194K Buy
+44,000
New +$194K 0.21% 67